Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2015-10-27 Capital/Financing Update
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an amendment to revolving credit agreements, which is a financing activity. The document also references non-GAAP financial information but does not present full financial statements or a comprehensive financial report. The primary focus is on the amendment to credit agreements, which is a capital/financing update. The document length is 8278 characters, which is sufficient for a substantive filing, not just a brief announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2015-10-27 English
PRIMARY DOCUMENT
Director's Dealing
2015-10-22 English
PRIMARY DOCUMENT
Director's Dealing
2015-10-22 English
PRIMARY DOCUMENT
Director's Dealing
2015-10-21 English
PRIMARY DOCUMENT
Director's Dealing
2015-10-21 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 21, 2015, reporting the appointment of a new director to the company's board. The key section is Item 5.02, which specifically addresses the departure or election of directors or certain officers. The content focuses on the election of Michael F. Mahoney to the board and related compensation details. There is no financial data, earnings information, or other report content. This matches the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is 3236 characters, which is consistent with a typical 8-K announcement of management changes rather than a full report. Therefore, the correct classification is MANG with high confidence.
2015-10-21 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.